What’s Behind The Jump In ImmunityBio Stock?

ImmunityBio, Inc. (NASDAQ:IBRX) shares are higher on Wednesday following news that the European Commission has authorized one of the company’s treatments for non-muscle invasive bladder cancer carcinoma. Why is ImmunityBio stock higher today? This approval marks a...